动脉瘤性蛛网膜下腔出血合并脊髓硬膜下血肿:一例报告与系统综述
该研究通过一例新发报告和系统综述,汇总了12例颅内蛛网膜下腔出血(SAH)合并脊髓硬膜下血肿(S-SDH)患者。结果显示,S-SDH多在SAH后平均5.8天出现,最常见于腰椎;8例临床恢复良好至完全,2例持续下肢瘫痪,2例死亡。预后不良(mRS>2)与初始脑血管造影阴性、SAH至S-SDH间隔更短、使用抗血栓药物、未行脑脊液引流及颈胸段S-SDH相关。
要点
- SAH后S-SDH罕见,多在平均5.8天后出现,腰椎最常见。
- 腰椎位置、延迟出现、脑脊液引流及未用抗血栓药者预后较好。
- 延迟出现且无显著神经功能缺损者,保守治疗可能足够。
核心结论
- S-SDH在动脉瘤性SAH背景下不常见;腰椎位置、延迟出现、脑脊液引流及未使用抗血栓药物与更好的预后相关。
- 对于延迟出现的S-SDH且无显著神经功能缺损的患者,保守治疗可能足够。
研究设计与样本
- 采用PRISMA指南进行系统文献综述,结合一例新报告病例,共纳入12例颅内SAH合并脊髓SDH患者。
主要发现
- 颅内自发性SAH来源包括8例动脉瘤、1例假性动脉瘤和3例血管造影阴性。
- Hunt-Hess分级范围为1至4级,SAH至S-SDH的平均时间为5.8天,S-SDH最常出现在腰椎。
- 8例患者临床恢复显著至完全,2例持续下肢瘫痪,2例死亡;改良Rankin量表(mRS)评分为0至6分,12例中4例mRS>2。
- 预后不良(mRS>2)的患者具有以下特征:初始脑血管造影阴性、SAH至S-SDH时间更短(0.8天 vs. 7.6天)、使用抗血栓药物、未行脑脊液引流、以及颈段或胸段S-SDH。
临床怎么用
- 对动脉瘤性SAH患者应警惕S-SDH,尤其在延迟出现神经功能恶化时。
- 对于延迟出现S-SDH且无显著神经功能缺损的患者,可考虑保守治疗。
- 脑脊液引流可能与更好的预后相关,抗血栓药物的使用可能与不良预后相关。
局限性
- 基于少量病例的系统综述,证据级别有限,结论需更多报告病例验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Spinal subdural hematoma (S-SDH) rarely occurs after aneurysmal subarachnoid hemorrhage (SAH). Little information is known regarding the management and prognosis of patients with both S-SDH and SAH. Here, we present an illustrative case and provide a systematic review of S-SDH in the setting of SAH. METHODS: A systematic literature review using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines revealed 11 previous cases of concurrent intracranial SAH and spinal SDH, which are presented with our new reported case. RESULTS: Intracranial sources of spontaneous SAH included 8 aneurysms, 1 pseudoaneurysm, and 3 angiogram-negative cases. Hunt Hess grades ranged from 1 to 4, mean time between SAH and S-SDH was 5.8 days, and S-SDH presented most frequently in the lumbar spine. Eight patients showed significant to complete clinical recovery, 2 had continued plegia of the lower extremities, and 2 expired. Modified Rankin scores (mRS) ranged from 0 to 6, with mRS >2 for 4 of 12 patients. Patients with a poor clinical outcome (mRS >2) had an initially negative cerebral angiogram, earlier presentation with less time between SAH and S-SDH (0.8 vs. 7.6 days), use of antithrombotic medication, no diversion of cerebrospinal fluid, and cervical or thoracic S-SDH. CONCLUSION: S-SDH is uncommon in the setting of aneurysmal SAH; better outcomes are associated with lumbar location, delayed presentation, cerebrospinal fluid diversion, and lack of antithrombotic use. Conservative treatment may be sufficient in patients with delayed S-SDH and lack of significant neurologic deficits. More reported cases will allow greater understanding of this clinical entity.
引用
- Rothrock RJ, Li AY, Rumsey J, et al. Aneurysmal Subarachnoid Hemorrhage with Spinal Subdural Hematoma: A Case Report and Systematic Review of the Literature. World Neurosurg. 2019. PMID: 31103768. doi:10.1016/j.wneu.2019.05.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。